A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
AstraZeneca
Canadian Cancer Trials Group
SWOG Cancer Research Network
University of Arizona
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Emory University